Risedronate Sodium Tablets, USP, 5 mg, Rx Only, 30-count bottle, Manufactured for: Macleods Pharma USA, Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., BAddi, HImchal Pradesh, INDIA, NDC 33342-107-07.
Published April 13, 2022 · Recall initiated: March 10, 2022
Summary
FDA records drug Class III recall D-0762-2022, published April 13, 2022 and initiated March 10, 2022. Recalling firm: Macleods Pharma Usa Inc; Status: Terminated; Reported quantity: 4872 bottles; Lot: Lot #: BRD2001A, Exp 5/2022. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
FAILED CONTENT UNIFORMITY SPECIFICATIONS
What to do
Voluntary: Firm initiated · Letter
Get an email if RISEDRONATE SODIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- RISEDRONATE SODIUM
- Manufacturer
- Macleods Pharma Usa Inc
- Distributor
- USA Nationwide
- Lot
- Lot #: BRD2001A, Exp 5/2022
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAccuretic (quinapril HCl/hydrochlorothiazide) tablets, 20 mg/12.5 mg*, 90 Tablets, Rx Only, Distributed by:April 13, 2022
- FDASYMJEPI (epinephrine injection, USP) 0.3 mg, (0.3 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton,April 13, 2022
- FDAquinapril HCl/hydrochlorothiazide tablets, 20 mg/25 mg*, 90 Tablets, Rx Only, Distributed by: Greenstone, LLC,April 13, 2022
- FDASYMJEPI (epinephrine injection, USP) 0.15 mg (0.15 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton,April 13, 2022
- FDAquinapril HCl/hydrochlorothiazide tablets, 20 mg/12.5 mg*, 90 Tablets bottles, Rx Only, Distributed by:April 13, 2022
- FDACequa (cyclosporine ophthalmic solution) 0.09%, packaged in 6 pouches x 10 single-use vials (0.25 mL each) perApril 13, 2022
Questions about this recall
Was Risedronate Sodium Tablets, USP, 5 mg, Rx Only, 30-count bottle, Manufactured for: Macleods Pharma USA, Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., BAddi, HImchal Pradesh, INDIA, NDC 33342-107-07. recalled?
Yes. FDA published recall D-0762-2022 on April 13, 2022. Reported hazard: FAILED CONTENT UNIFORMITY SPECIFICATIONS
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: RISEDRONATE SODIUM.